The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled study Po Mui Lam, M.D., Wing Hung Tam, M.B.Ch.B., Ronald Ching Wan Ma, M.B.B.Chir., Lai Ping Cheung, M.Med., Michelle Hang Yuet Tsui, M.B.B.S., Peter Chun Yip Tong, Ph.D., Francis Chun Chung Chow, M.B.B.S., Christopher Wai Kei Lam, Ph.D., Michael Ho Ming Chan, M.B.Ch.B., Juliana Chung Ngor Chan, M.D., Christopher John Haines, M.D. Fertility and Sterility Volume 96, Issue 2, Pages 445-451.e1 (August 2011) DOI: 10.1016/j.fertnstert.2011.05.085 Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions
Figure 1 Flow diagram of the randomized controlled trial. Fertility and Sterility 2011 96, 445-451.e1DOI: (10.1016/j.fertnstert.2011.05.085) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions